Skip to main content

Peer Review reports

From: COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Original Submission
15 Feb 2021 Submitted Original manuscript
16 Feb 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
18 Feb 2021 Editorially accepted
16 Mar 2021 Article published 10.1186/s13063-021-05137-4

You can find further information about peer review here.

Back to article page